Literature DB >> 23651699

Characterization and outcomes of iliac vessel injury in the 21st century: a review of the National Trauma Data Bank.

Margaret H Lauerman1, Denis Rybin, Gheorghe Doros, Jeffrey Kalish, Naomi Hamburg, Robert T Eberhardt, Alik Farber.   

Abstract

INTRODUCTION: Iliac vessel trauma (IVT) is traditionally associated with high mortality. We evaluated a modern series of patients with IVT to assess current outcomes and endovascular therapy use.
METHODS: We performed a retrospective review of the National Trauma Data Bank. Patients with IVT were stratified by blunt and penetrating mechanism and arterial and venous injury.
RESULTS: In blunt IVT, there was no significant difference in mortality between those with and without pelvic fractures (odds ratio [OR] 0.61, 95% confidence interval [CI] 0.36-1.06). In penetrating IVT, combined arterial and venous IVT was associated with higher mortality (OR 1.70, 95% CI 1.06-2.70) compared to isolated arterial IVT. Isolated venous IVT was associated with lower mortality (OR 0.55, 95% CI 0.35-0.85) compared to isolated arterial IVT. Endovascular stenting was utilized in 11.3% of blunt IVT with pelvic fractures, 6.3% of blunt IVT without pelvic fractures, and 1.8% of penetrating IVT.
CONCLUSION: Iliac Vessel Trauma has significant mortality. Endovascular intervention for IVT is applied sparingly.

Entities:  

Keywords:  iliac artery; iliac vein; vascular trauma

Mesh:

Year:  2013        PMID: 23651699     DOI: 10.1177/1538574413487260

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  2 in total

1.  Blunt traumatic iliac vein injury without pelvic fracture - A case report.

Authors:  Hiroyuki Takahashi; Tomohisa Shoko; Hiroyuki Okamoto; Takahumi Shimizu; Akiko Oshiro; Shinsuke Onishi; Yuka Morishita; Satosi Nara
Journal:  Trauma Case Rep       Date:  2021-02-10

Review 2.  Abdominal vascular hemorrhage.

Authors:  David V Feliciano
Journal:  Surg Open Sci       Date:  2021-11-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.